Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes

(2025) Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes. HemaSphere. e70073. ISSN 2572-9241

Abstract

Metadata

Item Type: Article
Copyright, Publisher and Additional Information:

Publisher Copyright: © 2025 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematology Association.

Dates:
  • Published: 22 January 2025
  • Accepted: 8 December 2024
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Health Sciences (York)
Depositing User: Pure (York)
Date Deposited: 21 Feb 2025 10:40
Last Modified: 21 Feb 2025 10:40
Published Version: https://doi.org/10.1002/hem3.70073
Status: Published
Refereed: Yes
Identification Number: 10.1002/hem3.70073
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Filename: HemaSphere_-_2025_-_Rombaut_-_Somatic_mutations_and_DNA_methylation_identify_a_subgroup_of_poor_prognosis_within_lower_risk.pdf

Description: HemaSphere - 2025 - Rombaut - Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk

Licence: CC-BY-NC-ND 2.5

Export

Statistics